No Difference on Adherence Between Immediate-Release Versus Extended-Release Dopamine Agonists in Uninsured Subjects with Parkinson's Disease.

Lisette Bazán-RodríguezAmin Cervantes-ArriagaRodrigo Llorens-ArenasHumberto Calderón-FajardoMaria C Rodriguez Oroz

Published in: Movement disorders clinical practice (2015)

Overall adherence in subjects with PD is low. Use of an extended-release over an immediate-release dopamine agonist formulation in this study population is not associated with a better adherence.

Keyphrases

uric acid
drug delivery
healthcare
type diabetes
metabolic syndrome
affordable care act